CoChat

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

Bassand, J.-P., Afzal, R., Eikelboom, J., Wallentin, L., Peters, R., Budaj, A., Fox, K. A.A., Joyner, C. D., Chrolavicius, S., Granger, C. B., Mehta, S., Yusuf, S., on behalf of the OASIS 5 and OASIS 6 Investigators · 2010 · European Heart Journal
Cited by 108

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

AIMS: In patients with acute coronary syndromes (ACS), the negative impact of baseline haemoglobin levels on ischaemic events, particularly death, is well established, but the association with bleeding risk is less well studied. The aim of this study was to assess the impact of baseline haemoglobin levels on major bleeding complications. METHODS AND RESULTS: Pooled analysis of OASIS 5 and 6 data involving 32 170 patients with ACS with and without ST-segment elevation was performed. The association between baseline haemoglobin and major bleeding or ischaemic events was examined using multiple regression model. MAIN OUTCOME MEASURES: were 30-day rates of major bleeding, death, and death/myocardial infarction (MI) analysed according to baseline haemoglobin levels. Baseline haemoglobin level independently predicted the risk of overall, procedure-related, and non-procedure-related major bleedings at 30 days [odds ratio (OR) 0.94, 95% CI 0.90-0.98; OR 0.94, 95% CI 0.90-0.99; and OR 0.89, 95% CI 0.83-0.95, respectively, per 1 g/dL haemoglobin increment above 10 g/dL]. In addition, a curvilinear relationship between baseline haemoglobin levels and death at 30 days was observed with a 6% decrease in the risk for every 1 g/dL haemoglobin increment above 10 g/dL up to 15.9 g/dL (OR 0.94, 95% CI 0.90-0.98) and a 19% increase above this value (OR 1.19, 95% CI, 0.98-1.43). A similar relationship for the composite outcome of death/MI was observed. CONCLUSION: A low baseline haemoglobin level is an independent predictor of the risk of major bleeding in ACS as well as of the risk of death and death and MI. Among other predictors of bleeding risk, baseline haemoglobin should be taken into account in patients presenting with ACS. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov number, NCT00139815. http://clinicaltrials.gov/ct2/show/NCT00139815?term=NCT00139815&rank=1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehp401

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 108

Metadata

Authors
Bassand, J.-P., Afzal, R., Eikelboom, J., Wallentin, L., Peters, R., Budaj, A., Fox, K. A. A., Joyner, C. D., Chrolavicius, S., Granger, C. B., Mehta, S., Yusuf, S., & on behalf of the OASIS 5 and OASIS 6 Investigators
Venue
European Heart Journal
Published
2009-10-12
Volume
31
Issue
1
Pages
50-58
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2117374168
Cited by
108
References
1
FWCI
4.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. https://app.cochat.ai/papers/10.1093/eurheartj/ehp401
The paper
Bassand, J.-P., Afzal, R., Eikelboom, J., Wallentin, L., Peters, R., Budaj, A., Fox, K. A. A., Joyner, C. D., Chrolavicius, S., Granger, C. B., Mehta, S., Yusuf, S., & on behalf of the OASIS 5 and OASIS 6 Investigators. (2010). Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. https://doi.org/10.1093/eurheartj/ehp401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.